S
Sanofi Portfolio holdings
AUM
$176M
This Quarter Return
+2.12%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$176M
AUM Growth
+$9.8M
(+5.9%)
Cap. Flow
+$9.61M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
OMDA
Omada Health, Inc. Common Stock
OMDA
|
+$9.61M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
MeiraGTx Holdings
MGTX
$603M
| $79.5M | 45.25% |
12,197,737
| – | – |
|
2
Novavax
NVAX
$1.29B
| $43.3M | 24.67% |
6,880,481
| – | – |
|
3
AnaptysBio
ANAB
$637M
| $18.2M | 10.38% |
821,917
| – | – |
|
4
Inhibrx
INBX
$401M
| $16.5M | 9.4% |
1,157,926
| – | – |
|
|
OMDA
5
Omada Health, Inc. Common Stock
OMDA
$1.24B
| $9.61M | 5.47% |
+524,903
| New | +$9.61M |
|
6
LAVA Therapeutics
LVTX
$41.2M
| $2.53M | 1.44% |
1,919,455
| – | – |
|
7
Eledon Pharmaceuticals
ELDN
$155M
| $2.21M | 1.26% |
814,980
| – | – |
|
|
INZY
8
DELISTED
Inozyme Pharma
INZY
| $1.77M | 1.01% |
443,255
| – | – |
|
|
IGMS
9
DELISTED
IGM Biosciences
IGMS
| $1.61M | 0.92% |
1,438,975
| – | – |
|
10
Q32 Bio
QTTB
$21.7M
| $364K | 0.21% |
244,083
| – | – |
|